Jacobson KA - Search Results

1

Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.

Mathôt RA, Gubbens-Stibbe JM, Soudijn W, Jacobson KA, Ijzerman AP, Danhof M. Mathôt RA, et al. Among authors: jacobson ka. J Pharmacol Exp Ther. 1995 Oct;275(1):245-53. J Pharmacol Exp Ther. 1995. PMID: 7562557 Free PMC article.

2

Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

IJzerman AP, Van Galen PJ, Jacobson KA. IJzerman AP, et al. Among authors: jacobson ka. Drug Des Discov. 1992;9(1):49-67. Drug Des Discov. 1992. PMID: 1457698 Free PMC article.

3

Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Baumgold J, Nikodijevic O, Jacobson KA. Baumgold J, et al. Among authors: jacobson ka. Biochem Pharmacol. 1992 Feb 18;43(4):889-94. doi: 10.1016/0006-2952(92)90257-j. Biochem Pharmacol. 1992. PMID: 1540242 Free PMC article.

4

Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Nikodijević O, Sarges R, Daly JW, Jacobson KA. Nikodijević O, et al. Among authors: jacobson ka. J Pharmacol Exp Ther. 1991 Oct;259(1):286-94. J Pharmacol Exp Ther. 1991. PMID: 1920121 Free PMC article.

5

Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo.

Fredholm BB, Jacobson KA, Jonzon B, Kirk KL, Li YO, Daly JW. Fredholm BB, et al. Among authors: jacobson ka. J Cardiovasc Pharmacol. 1987 Apr;9(4):396-400. doi: 10.1097/00005344-198704000-00003. J Cardiovasc Pharmacol. 1987. PMID: 2438501 Free PMC article.

6

Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.

Barone S, Churchill PC, Jacobson KA. Barone S, et al. Among authors: jacobson ka. J Pharmacol Exp Ther. 1989 Jul;250(1):79-85. J Pharmacol Exp Ther. 1989. PMID: 2746513 Free PMC article.

7

A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects.

Evoniuk G, Jacobson KA, Shamim MT, Daly JW, Wurtman RJ. Evoniuk G, et al. Among authors: jacobson ka. J Pharmacol Exp Ther. 1987 Sep;242(3):882-7. J Pharmacol Exp Ther. 1987. PMID: 3656117 Free PMC article.

8

Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.

IJzerman AP, van der Wenden EM, van Galen PJ, Jacobson KA. IJzerman AP, et al. Among authors: jacobson ka. Eur J Pharmacol. 1994 Jun 15;268(1):95-104. doi: 10.1016/0922-4106(94)90124-4. Eur J Pharmacol. 1994. PMID: 7925617 Free PMC article.

9

A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

van Galen PJ, van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, IJzerman AP, Stiles GL, Jacobson KA. van Galen PJ, et al. Among authors: jacobson ka. Mol Pharmacol. 1994 Jun;45(6):1101-11. Mol Pharmacol. 1994. PMID: 8022403 Free PMC article.

10

Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Von Lubitz DK, Lin RC, Melman N, Ji XD, Carter MF, Jacobson KA. Von Lubitz DK, et al. Among authors: jacobson ka. Eur J Pharmacol. 1994 Apr 21;256(2):161-7. doi: 10.1016/0014-2999(94)90241-0. Eur J Pharmacol. 1994. PMID: 8050467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

852 results

Search Page

Filters